Medical services featuring a clinical protocol wherein two distinct tumor-targeted gene vectors, one carrying a cytocidal gene (a mutated cyclin G1), and the other bearing an immunomodulatory cytokine gene (GM-CSF), are used in combination for cancer immunotherapy or cancer vaccination

'bear':27 'cancer':40,43 'carri':16 'clinic':5 'combin':38 'csf':34 'cyclin':22 'cytocid':18 'cytokin':30 'distinct':9 'featur':3 'g1':23 'gene':13,19,31 'gm':33 'gm-csf':32 'immunomodulatori':29 'immunotherapi':41 'medic':1 'mutat':21 'one':15 'protocol':6 'servic':2 'target':12 'tumor':11 'tumor-target':10 'two':8 'use':36 'vaccin':44 'vector':14 'wherein':7

GENEVIEVE PROTOCOL

Owners

Goods & Services